Choose what works for you and stay consistent
A narrative review published in the journal Nutrients found that patients on GLP-1 receptor agonists face measurable risks of deficiency in vitamin B12, vitamin D, iron, calcium, magnesium, and several B vitamins
What follow-up usually looks at Physicians often reassess: Symptoms and function: sleep, energy, libido, mood, cognition, and recovery
Moderation is the practical answer here
June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation